Birgit C. Schultes

2.0k total citations
53 papers, 1.1k citations indexed

About

Birgit C. Schultes is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Birgit C. Schultes has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Immunology and 21 papers in Molecular Biology. Recurrent topics in Birgit C. Schultes's work include Monoclonal and Polyclonal Antibodies Research (26 papers), Immunotherapy and Immune Responses (17 papers) and CAR-T cell therapy research (10 papers). Birgit C. Schultes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (26 papers), Immunotherapy and Immune Responses (17 papers) and CAR-T cell therapy research (10 papers). Birgit C. Schultes collaborates with scholars based in United States, Germany and Canada. Birgit C. Schultes's co-authors include Christopher F. Nicodemus, Ragupathy Madiyalakan, Theresa L. Whiteside, Richard P. Baum, A.A. Noujaim, Peyton T. Taylor, Jonathan S. Berek, Alan N. Gordon, William P. McGuire and L.M. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Birgit C. Schultes

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Birgit C. Schultes United States	19	558	405	393	374	334	53	1.1k
Jennifer A. Belisle United States	8	494 0.9×	123 0.3×	382 1.0×	155 0.4×	234 0.7×	8	898
J. Hilgers Netherlands	15	576 1.0×	647 1.6×	871 2.2×	88 0.2×	336 1.0×	25	1.3k
M. I. Colnaghi Italy	15	273 0.5×	402 1.0×	487 1.2×	126 0.3×	585 1.8×	26	1.1k
Lowell J. Underwood United States	12	212 0.4×	122 0.3×	420 1.1×	132 0.4×	244 0.7×	16	881
Jennifer A. A. Gubbels United States	10	353 0.6×	105 0.3×	293 0.7×	142 0.4×	255 0.8×	16	786
Grant D. MacLean Canada	23	921 1.7×	607 1.5×	967 2.5×	158 0.4×	523 1.6×	38	1.8k
Timothy J. O rsquo Brien United States	10	209 0.4×	153 0.4×	376 1.0×	115 0.3×	152 0.5×	10	651
R. L. Ceriani United States	12	355 0.6×	457 1.1×	566 1.4×	45 0.1×	222 0.7×	26	992
Tanja Schneider‐Merck Germany	13	474 0.8×	412 1.0×	415 1.1×	138 0.4×	354 1.1×	18	1.0k
J Schlom United States	19	481 0.9×	908 2.2×	661 1.7×	79 0.2×	564 1.7×	38	1.6k

Countries citing papers authored by Birgit C. Schultes

Since Specialization

Citations

This map shows the geographic impact of Birgit C. Schultes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit C. Schultes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit C. Schultes more than expected).

Fields of papers citing papers by Birgit C. Schultes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit C. Schultes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit C. Schultes. The network helps show where Birgit C. Schultes may publish in the future.

Co-authorship network of co-authors of Birgit C. Schultes

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit C. Schultes. A scholar is included among the top collaborators of Birgit C. Schultes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit C. Schultes. Birgit C. Schultes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwong, Brandon, Joseph Banuelos, Petro Starokadomskyy, et al.. (2024). POS0462 PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FOR THE TREATMENT OF AUTOIMMUNE DISEASE. Annals of the Rheumatic Diseases. 83. 1129–1130. 2 indexed citations

Guess, Jamey, Chia Lin Chu, Edward Cochran, et al.. (2018). Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer. Molecular Cancer Therapeutics. 18(2). 245–256. 18 indexed citations

Mehla, Kamiya, Jarrod R. Tremayne, James A. Grunkemeyer, et al.. (2017). Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunology Immunotherapy. 67(3). 445–457. 20 indexed citations

O’Callaghan, Katie, Allison Nelson, Greg Motz, et al.. (2017). Adaptability of Antibody-Coupled T Cell Receptor (ACTR) Engineered Autologous T Cells in Combination with Daratumumab over CAR-Based Approaches. Blood. 130. 3189–3189. 2 indexed citations

Schomburg, A., et al.. (2009). Are serum neopterin concentrations superior to other parameters in the differential diagnosis and prognostic assessment of Graves' disease?. Experimental and Clinical Endocrinology & Diabetes. 104(2). 123–129. 2 indexed citations

Schultes, Birgit C., et al.. (2008). Taxanes can enhance immunotherapy of cancer - importance of timing. Cancer Research. 68. 2068–2068. 1 indexed citations

Ehlen, Tom, P. Hoskins, David F. Miller, et al.. (2005). A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer. International Journal of Gynecological Cancer. 15(6). 1023–1034. 60 indexed citations

Gordon, Alan N., Birgit C. Schultes, Holly H. Gallion, et al.. (2004). CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients. Gynecologic Oncology. 94(2). 340–351. 66 indexed citations

Möbus, Volker, Richard P. Baum, R. Kreienberg, et al.. (2003). Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer. American Journal of Obstetrics and Gynecology. 189(1). 28–36. 44 indexed citations

10.

Nicodemus, Christopher F., et al.. (2002). Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies. Expert Review of Vaccines. 1(1). 35–48. 10 indexed citations

11.

Schultes, Birgit C., et al.. (2001). Characterization of an Anti-MUC1 Monoclonal Antibody with Potential as a Cancer Vaccine. PubMed. 20(5-6). 313–324. 22 indexed citations

12.

Noujaim, A.A., Birgit C. Schultes, Richard P. Baum, & Ragupathy Madiyalakan. (2001). Induction of CA125-Specific B and T Cell Responses in Patients Injected with MAb-B43.13—Evidence for Antibody-Mediated Antigen-Processing and Presentation of CA125 in Vivo. Cancer Biotherapy and Radiopharmaceuticals. 16(3). 187–203. 79 indexed citations

13.

Schultes, Birgit C., Chengsheng Zhang, Liyan Xue, A.A. Noujaim, & Ragupathy Madiyalakan. (1999). Immunotherapy of Human Ovarian Carcinoma with OVAREX ^TM MAb-B43.13 in a Human-PBL-SCID/BG Mouse Model. Hybridoma. 18(1). 47–55. 29 indexed citations

14.

Schultes, Birgit C., et al.. (1998). Anti-idiotype induction therapy: anti-CA125 antibodies (Ab 3 ) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab 1 ). Cancer Immunology Immunotherapy. 46(4). 201–212. 65 indexed citations

15.

Luo, Dong, Mei Geng, Birgit C. Schultes, et al.. (1998). Expression of a fusion protein of scFv–biotin mimetic peptide for immunoassay. Journal of Biotechnology. 65(2-3). 225–228. 24 indexed citations

16.

Madiyalakan, Ragupathy, Rong Yang, Birgit C. Schultes, Richard P. Baum, & A.A. Noujaim. (1997). OVAREX™ MAb-B43.13:IFN-γ Could Improve the Ovarian Tumor Cell Sensitivity to CA125-Specific Allogenic Cytotoxic T Cells. Hybridoma. 16(1). 41–45. 10 indexed citations

17.

Schlebusch, H., et al.. (1995). A Monoclonal Antiidiotypic Antibody ACA 125 Mimicking the Tumor-Associated Antigen CA 125 for Immunotherapy of Ovarian Cancer. Hybridoma. 14(2). 167–174. 28 indexed citations

18.

Schultes, Birgit C., J. Reinsberg, Uwe Wagner, et al.. (1994). Idiotypic cascades after injection of the monoclonal antibody OC125. Cell Biophysics. 24-25(1-3). 259–266. 3 indexed citations

19.

Schultes, Birgit C., J. Reinsberg, H. Schlebusch, et al.. (1993). Idiotypic Cascades after Injection of the Monoclonal Antibody OC125: A Study in a Mouse Model. Induction of Antibodies against OC125 and CA 125 after Immunization with an Anti-CA 125 (MAb OC125) Monoclonal Antibody by Activation of the Idiotypic Network. Clinical Chemistry and Laboratory Medicine (CCLM). 31(7). 427–32. 2 indexed citations

20.

Schultes, Birgit C., et al.. (1992). Purification and Characterization of Two Different Thymidine-5´-Triphosphosphate-Hydrolysing Enzymes in Human Serum. Biological Chemistry Hoppe-Seyler. 373(1). 237–248. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact